Background: The coronavirus disease 2019 (COVID-19) pandemic is thought to have
increased use of virtual care, but population-based studies are lacking. We aimed to assess the …

Background The COVID-19 pandemic has led to a notable increase in telemedicine adoption.
However, the impact of the pandemic on telemedicine use at a population level in rural …

PURPOSE Ibrutinib reduces mortality in chronic lymphocytic leukemia (CLL). It increases
the risk of atrial fibrillation (AF) and bleeding and there are concerns about heart failure (HF) …

Purpose It is currently unclear how the shift towards virtual care during the 2019 novel
coronavirus (COVID-19) pandemic may have impacted chronic disease management at a …

Background: There are limited data on the association of material deprivation with clinical
care and outcomes after atrial fibrillation (AF) diagnosis in jurisdictions with universal health …

Myotubular myopathy (MTM) is a severe X-linked disease without existing therapies. Here,
we show that tamoxifen ameliorates MTM-related histopathological and functional …

BACKGROUND Limited studies have evaluated population‐level temporal trends in mortality
and cause of death in patients with contemporary managed atrial fibrillation. This study …

Background Approximately 25% of outpatient antibiotic prescriptions are unnecessary
among family physicians in Canada. Minimizing unnecessary antibiotics is key for community …

Background Atherosclerotic disease is an important contributor to adverse outcomes in
patients with atrial fibrillation (AF). There is limited recognition of the association between statin …

Importance There are limited clinical trial data and discrepant recommendations regarding
use of anticoagulation therapy in patients with atrial fibrillation (AF) aged 65 to 74 years …